Modeling intra-mosquito dynamics of Zika virus and its dose-dependence confirms the low epidemic potential of Aedes albopictus
SUSCEPTIBILITY
Disease Vectors
Disease Outbreaks
0302 clinical medicine
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Aedes
INFECTION
MESH: Animals
MESH: Disease Outbreaks
Biology (General)
MESH: Models, Theoretical
Zika Virus Infection
NONHUMAN-PRIMATES
MESH: Aedes
Viral Load
3. Good health
REUNION ISLAND
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
MESH: Mosquito Vectors
MESH: Viral Load
Life Sciences & Biomedicine
Research Article
DENGUE
QH301-705.5
MESH: Zika Virus
Mosquito Vectors
MESH: Disease Vectors
Microbiology
CAPACITY
AEGYPTI
03 medical and health sciences
MESH: Zika Virus Infection
CULICIDAE
Virology
Animals
Humans
MESH: Saliva
Viremia
MESH: Viremia
Epidemics
Saliva
MESH: Epidemics
MESH: Humans
Science & Technology
CHIKUNGUNYA VIRUS
Zika Virus
RC581-607
Models, Theoretical
VECTOR COMPETENCE
Parasitology
Immunologic diseases. Allergy
DOI:
10.1371/journal.ppat.1009068
Publication Date:
2020-12-31T18:41:03Z
AUTHORS (7)
ABSTRACT
Originating from African forests, Zika virus (ZIKV) has now emerged worldwide in urbanized areas, mainly transmitted by Aedes aegypti mosquitoes. Although Aedes albopictus can transmit ZIKV experimentally and was suspected to be a ZIKV vector in Central Africa, the potential of this species to sustain virus transmission was yet to be uncovered until the end of 2019, when several autochthonous transmissions of the virus vectored by Ae. albopictus occurred in France. Aside from these few locally acquired ZIKV infections, most territories colonized by Ae. albopictus have been spared so far. The risk level of ZIKV emergence in these areas remains however an open question. To assess Ae. albopictus’ vector potential for ZIKV and identify key virus outbreak predictors, we built a complete framework using the complementary combination of (i) dose-dependent experimental Ae. albopictus exposure to ZIKV followed by time-dependent assessment of infection and systemic infection rates, (ii) modeling of intra-human ZIKV viremia dynamics, and (iii) in silico epidemiological simulations using an Agent-Based Model. The highest risk of transmission occurred during the pre-symptomatic stage of the disease, at the peak of viremia. At this dose, mosquito infection probability was estimated to be 20%, and 21 days were required to reach the median systemic infection rates. Mosquito population origin, either temperate or tropical, had no impact on infection rates or intra-host virus dynamic. Despite these unfavorable characteristics for transmission, Ae. albopictus was still able to trigger and yield large outbreaks in a simulated environment in the presence of sufficiently high mosquito biting rates. Our results reveal a low but existing epidemic potential of Ae. albopictus for ZIKV, that might explain the absence of large scale ZIKV epidemics so far in territories occupied only by Ae. albopictus. They nevertheless support active surveillance and eradication programs in these territories to maintain the risk of emergence to a low level.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (87)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....